Aligo Alfa

Overview

Aligo Alfa is a venture capital firm based in Poland, specializing in early-stage investments in technology-driven companies. The firm focuses on sectors such as HealthTech, CleanTech, MedTech, Biotech, Digital Healthcare, and Life Science, aiming to support projects that address global challenges and promote sustainable development. Aligo Alfa often acts as the sole investor or co-invests in funding rounds, with investment tickets ranging from €200,000 to €500,000. The firm's investment strategy emphasizes scalability and global reach, backing founders who start in Poland but have business ambitions beyond national borders. Aligo Alfa is particularly interested in projects that utilize technology to reduce the negative impact of the economy on the environment and to improve human health. The firm also offers consulting services to help portfolio companies secure additional funding, including domestic and international grants, to accelerate their growth. Aligo Alfa's portfolio includes companies in various sectors, such as dietary supplements for dermatological issues, digital therapeutics for cancer patients, and innovations in image-based diagnostics. The firm has a team with extensive experience in venture capital, including professionals who have managed corporate venture funds and have backgrounds in capital markets. Aligo Alfa is committed to supporting innovative entrepreneurs and technologies that have a meaningful impact on society and the environment.

Investment Focus

• Projects in pre-seed and seed stages
• Focus on HealthTech, CleanTech, MedTech, Biotech, Digital Healthcare, and Life Science sectors
• Potential for scalability and global reach
• Use of technology to address environmental and health challenges
• Interest in securing additional funding through grants and other sources

Portfolio Companies